Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer.

Garinet S, Pignot G, Vacher S, Le Goux C, Schnitzler A, Chemlali W, Sirab N, Barry Delongchamps N, Zerbib M, Sibony M, Allory Y, Damotte D, Bieche I.

Mol Cancer Res. 2019 Feb;17(2):469-475. doi: 10.1158/1541-7786.MCR-18-0363. Epub 2018 Nov 6.

PMID:
30401719
2.

mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.

Le Goux C, Vacher S, Pignot G, Sibony M, Barry Delongchamps N, Terris B, Piaggio E, Zerbib M, Damotte D, Bieche I.

Oncoimmunology. 2017 Aug 14;6(11):e1358330. doi: 10.1080/2162402X.2017.1358330. eCollection 2017.

3.

Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.

Le Goux C, Damotte D, Vacher S, Sibony M, Delongchamps NB, Schnitzler A, Terris B, Zerbib M, Bieche I, Pignot G.

Urol Oncol. 2017 May;35(5):257-263. doi: 10.1016/j.urolonc.2017.01.014. Epub 2017 Mar 11.

PMID:
28291636
4.

[Recent advances in bladder urothelial carcinogenesis].

Pignot G, le Goux C, Bieche I.

Bull Cancer. 2015 Dec;102(12):1020-35. doi: 10.1016/j.bulcan.2015.10.004. Epub 2015 Nov 23. Review. French.

5.

Curage ganglionnaire dans la chirurgie du corticosurrénalome.

Le Goux C, Gaujoux S, Dousset B.

Prog Urol. 2015 Nov;25(13):858. doi: 10.1016/j.purol.2015.08.287. French. No abstract available.

PMID:
26544481
6.

Implication de la voie PD1/PDL1 et de la voie CTLA4/CD80 dans les tumeurs urothéliales.

Pignot G, Le Goux C, Bieche I, Vacher S, Barry de Longchamps N, Sibony M, Zerbib M.

Prog Urol. 2015 Nov;25(13):762. doi: 10.1016/j.purol.2015.08.096. French. No abstract available.

PMID:
26544291
7.

[Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma].

Bruzzi M, Le Goux C, Pignot G, Amsellem-Ouazana D, Vieillefond A, Patard JJ, Zerbib M.

Prog Urol. 2014 Jul;24(9):556-62. doi: 10.1016/j.purol.2013.12.005. Epub 2014 Jan 21. French.

PMID:
24975790
8.

Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.

Pignot G, Salomon L, Neuzillet Y, Masson-Lecomte A, Lebacle C, Patard JJ, Lunardi P, Rischmann P, Pasticier G, Bernhard JC, Cohen J, Timsit MO, Verkarre V, Peyronnet B, Verhoest G, Le Goux C, Zerbib M, Brecheteau F, Bigot P, Larre S, Murez T, Thuret R, Lacarriere E, Champy C, Roupret M, Comperat E, Berger J, Descazeaud A, Toledano H, Bastide C, Lavilledieu S, Avances C, Delage F, Valeri A, Molimard B, Houlgatte A, Gres P, Donnaint A, Kleinclauss F, Legal S, Doerfler A, Koutlidis N, Cormier L, Hetet JF, Colls P, Arvin-Berod A, Rambeaud JJ, Quintens H, Soulie M, Pfister C; Oncologic Committee of the French Association of Urology.

Ann Surg Oncol. 2014 Feb;21(2):684-90. doi: 10.1245/s10434-013-3340-8. Epub 2013 Oct 30.

PMID:
24170436
9.

[Pronostic value of ureteral location of upper tract urinary carcinoma].

Le Goux C, Pignot G, Amsellem-Ouazana D, Vieillefond A, Peyromaure M, Flam T, Debré B, Zerbib M.

Prog Urol. 2013 May;23(6):399-404. doi: 10.1016/j.purol.2013.01.025. Epub 2013 Mar 6. French.

PMID:
23628098

Supplemental Content

Loading ...
Support Center